Lower phenytoin serum levels in persons switched from brand to generic phenytoin
Jefferys, R.J.
Neurology 65(4): 657-8; Author Reply 657-8
2005
ISSN/ISBN: 0028-3878 PMID: 16116145 Document Number: 584431
Document emailed within 1 workday
Related Documents
1980: Dilantin vs generic phenytoin sodium Medical Letter on Drugs and Therapeutics 22(12): 49-50Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Kariks, J.; Perry, S.W.; Wood, D. 1971: Serum folic acid and phenytoin levels in permanently hospitalized epileptic patients receiving anticonvulsant drug therapy Medical Journal of Australia 2(7): 368-371
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Edmundson, W.F.; Frazier, D.E.; Maceo, A. 1972: Sequential biochemical tests in persons taking PH phenytoin Ims Industrial Medicine and Surgery 41(4): 7-11
Bruni, J.; Wilder, B.J.; Willmore, L.J.; Barbour, B. 1979: Valproic acid and plasma levels of phenytoin Neurology 29(6): 904-905
Baylis, E.M.; Crowley, J.M.; Preece, J.M.; Sylvester, P.E.; Marks, V. 1971: Influence of folic acid on blood-phenytoin levels Lancet 1(7689): 62-64
Buchanan, N.; van der Walt, L.A. 1977: The binding of phenobarbitone and phenytoin to kwashiorkor serum South African Medical Journal 52(13): 518-521
Sommer, R.; Nelson, C.; Greenquist, A. 1986: Dry-reagent strips for measuring phenytoin in serum Clinical Chemistry 32(9): 1770-1774
Talesnik, E.; Rivero, S.J.; González, B. 1989: Serum IgA deficiency induced by prolonged phenytoin treatment Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 41(4): 331-335
Maurat, J.P.; Bugnon, C.; Rousselet, F.; Fellmann, D.; Becque, O.; Techenet, P. 1978: Effect of long-term phenytoin treatment on the levels of calcium and magnesium in rat femurs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 172(6): 1114-1118
Liamsuwan, S.; Jaiweerawattana, U. 2011: Correlation between serum and salivary phenytoin concentrations in Thai epileptic children Journal of the Medical Association of Thailand 94(Suppl 3): S172-S177
Huang, Y.; Yang, J-Fang.; Qi, X-Lian.; Wang, Y-Qin.; Wang, W-Zhi.; Chen, B. 2004: Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration Zhonghua Yi Xue Za Zhi 84(20): 1686-1689
Wierzchowiecki, M.; Masiakowski, J.; Dyderski, S.; Cieszyński, T.; Jankowiak, M. 1987: Therapy monitored by the measurement of phenytoin levels in patients with ventricular disorders of cardiac rhythm Kardiologia Polska 30(9): 583-588
Wässer, S.; Jalinski, W.; Quednow, B.; Walther, H. 1984: Initial therapeutic results in epileptic children with and without serum-controlled phenytoin treatment Padiatrie und Grenzgebiete 23(1): 11-14
Dasgupta, A.; Dennen, D.A.; Dean, R.; McLawhon, R.W. 1991: Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole Clinical Chemistry 37(1): 98-100
Otoom, S.; Bakhiet, M.; Khan, A.; Sequeira, R. 2006: Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders Neuro Endocrinology Letters 27(1-2): 85-88
Tiula, E.; Haapanen, E.J.; Neuvonen, P.J. 1987: Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases International Journal of Clinical Pharmacology Therapy and Toxicology 25(9): 469-475
Szabo, G.K.; Browne, T.R. 1982: Improved isocratic liquid-chromatographic simultaneous measurement of phenytoin, phenobarbital, primidone, carbamazepine, ethosuximide, and N-desmethylmethsuximide in serum Clinical Chemistry 28(1): 100-104
Puche, E.; Garcia Morillas, M.; Garcia de la Serrana, H.; Mota, C. 1989: Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increased serum aspirin-esterase activity in epileptics International Journal of Clinical Pharmacology Research 9(5): 309-311